All content for OncoTalks | Oncology Insights at Your Fingertips is the property of Ontada Learn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
HER2-low Uncovered: A Phase 1 Retrospective Study on Testing & Concordant Treatment
OncoTalks | Oncology Insights at Your Fingertips
17 minutes 47 seconds
8 months ago
HER2-low Uncovered: A Phase 1 Retrospective Study on Testing & Concordant Treatment
Join us for the conclusion of our 2-part series on HER2-low breast cancer, featuring Dr. Paul Conkling and Dr. Erika Hamilton. They discuss the Phase 1 results from a HER2-low retrospective study evaluating HER2 testing patterns and concordant therapy in patients with HER2 metastatic breast cancer. Learn about the evolving role of HER2-low classification, ongoing education, and treatment strategies to enhance patient outcomes.
